Skip to main content
. 2020 Mar 14;19:111. doi: 10.1186/s12936-020-03184-x

Table 2.

Frequency of NPAEs with high-dose tafenoquine/chloroquine in vivax malaria patients [81]

Adverse event, n (%) Tafenoquine
300 mg q.d. × 7 days (N = 18)
Tafenoquine
600 mg q.d. × 3 days (N = 19)
Tafenoquine
600 mg single dose (N = 18)
Primaquine
15 mg q.d. × 14 days (N = 12)
Any NPAE 8 (44) 8 (42) 4 (22) 6 (50)
Vertigo 8 (44) 8 (42) 4 (22) 3 (25)
Headache 4 (22) 4 (21) 2 (11) 4 (33)